UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CaFe2O4 oxygen carrier characterization during the partial oxidation of coal in the chemical looping gasification application

Applied energy, 2018-08, Vol.224 (C), p.708-716

2018

Volltextzugriff (PDF)

Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy

Molecules (Basel, Switzerland), 2017-08, Vol.22 (8), p.1281

2017

Volltextzugriff (PDF)

Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug Resistance

Current medicinal chemistry, 2020-01, Vol.27 (39), p.6573-6595

2020

Volltextzugriff (PDF)

Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy

Medicinal research reviews, 2019-07, Vol.39 (4), p.1398-1426

2019

Volltextzugriff (PDF)

Non-Musculoskeletal Benefits of Vitamin D beyond the Musculoskeletal System

International journal of molecular sciences, 2021-02, Vol.22 (4), p.2128

2021

Volltextzugriff (PDF)

Discovery of 4‑Aryl-2-benzoyl-imidazoles as Tubulin Polymerization Inhibitor with Potent Antiproliferative Properties

Journal of medicinal chemistry, 2013-04, Vol.56 (8), p.3318-3329

2013

Volltextzugriff (PDF)

Role of lysophosphatidic acid and its receptors in the kidney

Physiological genomics, 2017-11, Vol.49 (11), p.659-666

2017

Volltextzugriff (PDF)

Design, Synthesis, and Biological Evaluation of Stable Colchicine-Binding Site Tubulin Inhibitors 6-Aryl-2-benzoyl-pyridines as Potential Anticancer Agents

Journal of medicinal chemistry, 2021-08, Vol.64 (16), p.12049-12074

2021

Volltextzugriff (PDF)

Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1

Current drug metabolism, 2015-01, Vol.16 (6), p.486-503

2015

Volltextzugriff (PDF)

Current Advances of Tubulin Inhibitors in Nanoparticle Drug Delivery and Vascular Disruption/Angiogenesis

Molecules, 2016-11, Vol.21 (11), p.1468

2016

Volltextzugriff (PDF)

An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer

International journal of molecular sciences, 2021-02, Vol.22 (4), p.2124

2021

Volltextzugriff (PDF)

Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective

Drug discovery today, 2022-03, Vol.27 (3), p.759-776

2022

Volltextzugriff (PDF)

Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV‑2 Main Protease Inhibitor: Insights from a Computational and In Vitro Study

Journal of chemical information and modeling, 2021-11, Vol.61 (11), p.5469-5483

2021

Volltextzugriff (PDF)

Selective androgen receptor modulators (SARMs) negatively regulate triple-negative breast cancer growth and epithelial:mesenchymal stem cell signaling

PloS one, 2014-07, Vol.9 (7), p.e103202

2014

Volltextzugriff (PDF)

Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer

Cancer research (Chicago, Ill.), 2017-11, Vol.77 (22), p.6282-6298

2017

Volltextzugriff (PDF)

An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site

Pharmaceutical research, 2012-11, Vol.29 (11), p.2943-2971

2012

Volltextzugriff (PDF)

DJ-X-013 reduces LPS-induced inflammation, modulates Th17/ myeloid-derived suppressor cells, and alters NF-κB expression to ameliorate experimental colitis

Biomedicine & pharmacotherapy, 2024-10, Vol.179, p.117379-117379, Article 117379

2024

Volltextzugriff (PDF)

Highly Potent Non-Carboxylic Acid Autotaxin Inhibitors Reduce Melanoma Metastasis and Chemotherapeutic Resistance of Breast Cancer Stem Cells

Journal of medicinal chemistry, 2017-02, Vol.60 (4), p.1309-1324

2017

Volltextzugriff (PDF)

Discovery of 4-Substituted Methoxybenzoyl-aryl-thiazole as Novel Anticancer Agents: Synthesis, Biological Evaluation, and Structure−Activity Relationships

Journal of medicinal chemistry, 2009-03, Vol.52 (6), p.1701-1711

2009

Volltextzugriff (PDF)

The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma

Frontiers in pharmacology, 2021-03, Vol.12, p.637098

2021

Volltextzugriff (PDF)

Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis

Biochemical Society transactions, 2012-02, Vol.40 (1), p.31-36

2012

Volltextzugriff (PDF)

Nonsteroidal Selective Androgen Receptor Modulators (SARMs): Dissociating the Anabolic and Androgenic Activities of the Androgen Receptor for Therapeutic Benefit

Journal of medicinal chemistry, 2009-06, Vol.52 (12), p.3597-3617

2009

Volltextzugriff (PDF)

Interaction of manganese with aluminosilicate support during high temperature (1100 °C) chemical looping combustion of the Fe-Mn-based oxygen carrier

Fuel (Guildford), 2020-03, Vol.263 (C), p.116738, Article 116738

2020

Volltextzugriff (PDF)

Targeting the Bromodomain of BRG-1/BRM Subunit of the SWI/SNF Complex Increases the Anticancer Activity of Temozolomide in Glioblastoma

Pharmaceuticals (Basel, Switzerland), 2021-09, Vol.14 (9), p.904

2021

Volltextzugriff (PDF)

Structural Basis for Antagonism and Resistance of Bicalutamide in Prostate Cancer

Proceedings of the National Academy of Sciences - PNAS, 2005-04, Vol.102 (17), p.6201-6206

2005

Volltextzugriff (PDF)

1 – 25 von 553

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(508)
Mit Volltextzugriff
(504)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(553)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(322)
Life Sciences & Biomedicine
(276)
Animals
(232)
Humans
(191)
Pharmacology & Pharmacy
(190)
Male
(121)
Rats
(113)
Chemistry, Medicinal
(111)
Biological And Medical Sciences
(109)
Chemistry
(101)
Medical Sciences
(101)
Structure-Activity Relationship
(93)
Pharmacology. Drug Treatments
(92)
Mice
(81)
Physical Sciences
(81)
Cell Line, Tumor
(71)
Antineoplastic Agents - Pharmacology
(51)
Female
(49)
Rats, Sprague-Dawley
(48)
In Vitro Techniques
(47)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

CaFe2O4 oxygen carrier characterization during the partial oxidation of coal in the chemical looping gasification application

Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy

Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug Resistance

Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy

Non-Musculoskeletal Benefits of Vitamin D beyond the Musculoskeletal System

Discovery of 4‑Aryl-2-benzoyl-imidazoles as Tubulin Polymerization Inhibitor with Potent Antiproliferative Properties

Role of lysophosphatidic acid and its receptors in the kidney

Design, Synthesis, and Biological Evaluation of Stable Colchicine-Binding Site Tubulin Inhibitors 6-Aryl-2-benzoyl-pyridines as Potential Anticancer Agents

Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1

Current Advances of Tubulin Inhibitors in Nanoparticle Drug Delivery and Vascular Disruption/Angiogenesis

An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer

Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective

Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV‑2 Main Protease Inhibitor: Insights from a Computational and In Vitro Study

Selective androgen receptor modulators (SARMs) negatively regulate triple-negative breast cancer growth and epithelial:mesenchymal stem cell signaling

Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer

An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site

DJ-X-013 reduces LPS-induced inflammation, modulates Th17/ myeloid-derived suppressor cells, and alters NF-κB expression to ameliorate experimental colitis

Highly Potent Non-Carboxylic Acid Autotaxin Inhibitors Reduce Melanoma Metastasis and Chemotherapeutic Resistance of Breast Cancer Stem Cells

Discovery of 4-Substituted Methoxybenzoyl-aryl-thiazole as Novel Anticancer Agents: Synthesis, Biological Evaluation, and Structure−Activity Relationships

The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma

Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis

Nonsteroidal Selective Androgen Receptor Modulators (SARMs): Dissociating the Anabolic and Androgenic Activities of the Androgen Receptor for Therapeutic Benefit

Interaction of manganese with aluminosilicate support during high temperature (1100 °C) chemical looping combustion of the Fe-Mn-based oxygen carrier

Targeting the Bromodomain of BRG-1/BRM Subunit of the SWI/SNF Complex Increases the Anticancer Activity of Temozolomide in Glioblastoma

Structural Basis for Antagonism and Resistance of Bicalutamide in Prostate Cancer

Suchergebnisse filtern